Increasing prevalence of infectious diseases and need for therapeutic drug monitoring are key factors driving market revenue growth.
Market Size - USD 1,453.7 Million in 2020, Market Growth - CAGR of 6.6%, Market Trends - Increasing funding for research and favorable regulatory scenario by government of various countries.
The global therapeutic drug monitoring market size is expected to reach USD 2,429.1 Million in 2028, and register a CAGR of 6.6% during the forecast period. Increasing organ transplantation incidences resulting in high adoption of therapeutic drug monitoring technique, rising investments from government and private companies for research funding, strategic planning by major players such as mergers and acquisitions, partnerships, agreements, etc.
Therapeutic Drug Monitoring (TDM) is a branch of clinical pharmacology and chemistry, which measures and maintains specific drug concentration levels in body fluids or blood streams. The monitoring process is aimed at refining patient care for better outcomes by adjusting the drug dosage.
Some Key Findings From the Report:
For the purpose of this report, the global therapeutic drug monitoring market is segmented on the basis of product type, technology type, drug type, end use, and region:
Product Type
Technology Type
Class of Drug Type
End Use
Region Outlook
Reasons to Buy the Report
Market Size - USD 1,453.7 Million in 2020, Market Growth - CAGR of 6.6%, Market Trends - Increasing funding for research and favorable regulatory scenario by government of various countries.
The global therapeutic drug monitoring market size is expected to reach USD 2,429.1 Million in 2028, and register a CAGR of 6.6% during the forecast period. Increasing organ transplantation incidences resulting in high adoption of therapeutic drug monitoring technique, rising investments from government and private companies for research funding, strategic planning by major players such as mergers and acquisitions, partnerships, agreements, etc.
Therapeutic Drug Monitoring (TDM) is a branch of clinical pharmacology and chemistry, which measures and maintains specific drug concentration levels in body fluids or blood streams. The monitoring process is aimed at refining patient care for better outcomes by adjusting the drug dosage.
Some Key Findings From the Report:
- Among the product type segments, the equipment segment accounted for the largest revenue share of 54.6% in 2020.
- Among the end use segments, the hospital laboratories segment accounted for major revenue share in 2020, owing to large number of patient footfalls in hospitals.
- North America market accounted for the largest revenue share in the global market in 2020, and is expected to continue with its dominance over the forecast period, due to presence of major players operating in countries in the region.
- The Asia Pacific market size was USD 334.4 Million in 2020. Revenue from the Asia Pacific market is expected to expand at a robust growth rate during the forecast period.
- Key players profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche AG (Roche Diagnostics), Bio-Rad Laboratories Inc., Beckman Coulter, Inc., Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Alpco, and Randox Laboratories Ltd. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global therapeutic drug monitoring market is segmented on the basis of product type, technology type, drug type, end use, and region:
Product Type
- Consumables
- Equipment
Technology Type
- Immunoassays
- Colorimetric Immunoassays
- Radioimmunoassays
- Other Immunoassays
- Chromatography-MS
Class of Drug Type
- Antiepileptic Drugs
- Antiarrhythmic Drugs
- Immunosuppressant Drugs
- Antibiotic Drugs
- Bronchodilator Drugs
- Psychoactive Drugs
- Other Drug Classes
End Use
- Hospital Laboratories
- Commercial/Private Laboratories
- Other End Users
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Therapeutic Drug Monitoring Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Therapeutic Drug Monitoring Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Therapeutic Drug Monitoring Segmentation & Impact Analysis
Chapter 5. Therapeutic Drug Monitoring Market By Product Type Insights & Trends
Chapter 6. Therapeutic Drug Monitoring Market By Technology Type Insights & Trends
Chapter 7. Therapeutic Drug Monitoring Market By Class of Drug Type Insights & Trends
Chapter 8. Therapeutic Drug Monitoring Market By End Use Insights & Trends
Chapter 9. Therapeutic Drug Monitoring Market Regional Outlook
Chapter 10. Competitive Landscape
Chapter 11. Company Profiles